Alexandre E. Voskuyl

19.3k total citations
246 papers, 9.2k citations indexed

About

Alexandre E. Voskuyl is a scholar working on Rheumatology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alexandre E. Voskuyl has authored 246 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 170 papers in Rheumatology, 65 papers in Pathology and Forensic Medicine and 43 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alexandre E. Voskuyl's work include Rheumatoid Arthritis Research and Therapies (111 papers), Systemic Lupus Erythematosus Research (99 papers) and Systemic Sclerosis and Related Diseases (48 papers). Alexandre E. Voskuyl is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (111 papers), Systemic Lupus Erythematosus Research (99 papers) and Systemic Sclerosis and Related Diseases (48 papers). Alexandre E. Voskuyl collaborates with scholars based in Netherlands, United States and United Kingdom. Alexandre E. Voskuyl's co-authors include Ben A. C. Dijkmans, Michael T. Nurmohamed, Willem F. Lems, Maarten Boers, Irene E. M. Bultink, Vokko P. van Halm, Conny J. van der Laken, Gertjan Wolbink, Yvo M. Smulders and Jos W. R. Twisk and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Alexandre E. Voskuyl

232 papers receiving 8.9k citations

Peers

Countries citing papers authored by Alexandre E. Voskuyl

Since Specialization

Citations

This map shows the geographic impact of Alexandre E. Voskuyl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre E. Voskuyl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre E. Voskuyl more than expected).

Fields of papers citing papers by Alexandre E. Voskuyl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre E. Voskuyl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre E. Voskuyl. The network helps show where Alexandre E. Voskuyl may publish in the future.

Co-authorship network of co-authors of Alexandre E. Voskuyl

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre E. Voskuyl. A scholar is included among the top collaborators of Alexandre E. Voskuyl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre E. Voskuyl. Alexandre E. Voskuyl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Concentrations of subcutaneously administered belimumab in human breast milk of a woman with systemic lupus erythematosus: a case report 2024 ·Lupus Science & Medicine ·(unknown), Marjon A. de Boer, Mirjam M. van Weissenbruch, (unknown), Theo Rispens, Alexandre E. Voskuyl, Irene E. M. Bultink	3
2	Early prediction of treatment response in rheumatoid arthritis by quantitative macrophage PET 2022 ·RMD Open ·(unknown), Gerben J.C. Zwezerijnen, Marieke M. ter Wee, (unknown), Maqsood Yaqub, Dirkjan van Schaardenburg, Adriaan A. Lammertsma, Alexandre E. Voskuyl, Willem F. Lems, Maarten Boers, (unknown)	7
3	Whole-Body Macrophage Positron Emission Tomography Imaging for Disease Activity Assessment in Early Rheumatoid Arthritis 2022 ·The Journal of Rheumatology ·(unknown), (unknown), Marieke M. ter Wee, Gerben J.C. Zwezerijnen, Maqsood Yaqub, Alexandre E. Voskuyl, Adriaan A. Lammertsma, Dirkjan van Schaardenburg, Maarten Boers, Willem F. Lems, Conny J. van der Laken	1
4	Recurrence risk of venous thromboembolism associated with systemic lupus erythematosus: A retrospective cohort study 2022 ·Research and Practice in Thrombosis and Haemostasis ·(unknown), (unknown), (unknown), Paul Van Daele, (unknown), Alexandre E. Voskuyl, Maarten Limper, Robbert J Goekoop, (unknown), (unknown), Marc Bijl, (unknown), (unknown), Hein J. Bernelot Moens, Karina de Leeuw, Karina Meijer	7
5	Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trial 2021 ·Osteoporosis International ·(unknown), Marieke M. ter Wee, Debby den Uyl, (unknown), Michael T. Nurmohamed, Alexandre E. Voskuyl, Dirkjan van Schaardenburg, P. J. S. M. Kerstens, Irene E. M. Bultink, Maarten Boers, Willem F. Lems	3
6	Predictors of fatal and non-fatal cardiovascular events in ANCA-associated vasculitis: Data from the Toronto CanVasc cohort 2020 ·Joint Bone Spine ·Eline Houben, Arielle Mendel, Simon Carette, Alexandre E. Voskuyl, E. Lars Penne, Christian Pagnoux	14
7	From “being at war” to “getting back on your feet”: A qualitative study on experiences of patients with systemic sclerosis treated with hematopoietic stem cell transplantation 2020 ·Journal of Scleroderma and Related Disorders ·Julia Spierings, (unknown), (unknown), Arwen H. Pieterse, Madelon C Vonk, Alexandre E. Voskuyl, Jeska K de Vries‐Bouwstra, J.M. van Laar, Marijke C. Kars	5
8	Should vascular wall 18F-FDG uptake be adjusted for the extent of atherosclerotic burden? 2020 ·International journal of cardiac imaging ·(unknown), Alexandre E. Voskuyl, Emile F.I. Comans, Conny J. van der Laken, Ronald Boellaard, Yvo M. Smulders	2
9	Cardiovascular Event Risk in Rheumatoid Arthritis Compared with Type 2 Diabetes: A 15-year Longitudinal Study 2019 ·The Journal of Rheumatology ·Rabia Agca, Luuk H G A Hopman, (unknown), Vokko P. van Halm, Mike J.L. Peters, Yvo M. Smulders, Joost Dekker, Giel Nijpels, Coen D.A. Stehouwer, Alexandre E. Voskuyl, Maarten Boers, Willem F. Lems, Michael T. Nurmohamed	35
10	How do patients with systemic sclerosis experience currently provided healthcare and how should we measure its quality? 2019 ·Lara D. Veeken ·Julia Spierings, C.H.M. van den Ende, (unknown), Hein J. Bernelot Moens, (unknown), Femke Bonte‐Mineur, (unknown), (unknown), (unknown), Jacob M. van Laar, Douwe J. Mulder, Judith Potjewijd, (unknown), (unknown), Anne A. Schouffoer, Alja J. Stel, (unknown), Alexandre E. Voskuyl, Jeska K de Vries‐Bouwstra, Madelon C Vonk, (unknown)	13
11	Treatment decision-making in diffuse cutaneous systemic sclerosis: a patient’s perspective 2019 ·Lara D. Veeken ·Julia Spierings, (unknown), (unknown), (unknown), Arwen H. Pieterse, Madelon C Vonk, Alexandre E. Voskuyl, Jeska K de Vries‐Bouwstra, Marijke C. Kars, Jacob M. van Laar	14
12	Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial 2017 ·RMD Open ·Marieke M. ter Wee, Veerle M.H. Coupé, Debby den Uyl, (unknown), (unknown), P. J. S. M. Kerstens, Michael T. Nurmohamed, Dirkjan van Schaardenburg, Alexandre E. Voskuyl, Maarten Boers, Willem F. Lems	5
13	Cardiovascular events in anti-neutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies 2017 ·Lara D. Veeken ·Eline Houben, E. Lars Penne, Alexandre E. Voskuyl, Joost W van der Heijden, René H.J. Otten, Maarten Boers, Tiny Hoekstra	63
14	OP0310 Pregnancy outcome in women with systemic lupus erythematosus, a multicenter cohort-study 2017 ·Annals of the Rheumatic Diseases ·(unknown), Carolien N. H. Abheiden, (unknown), Jacob M. van Laar, R. H. W. M. Derksen, (unknown), Alexandre E. Voskuyl, A. Titia Lely, Marjon A. de Boer, Jip de Vries, Ruth Fritsch‐Stork	1
15	Anti-Hinge Antibodies Recognize IgG Subclass– and Protease-Restricted Neoepitopes 2016 ·The Journal of Immunology ·(unknown), Dirkjan van Schaardenburg, Pleuni Ooijevaar‐de Heer, Michel Tsang-A-Sjoe, Irene E. M. Bultink, Alexandre E. Voskuyl, Arthur E. H. Bentlage, Gestur Vidarsson, Gertjan Wolbink, Theo Rispens	23
16	Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis. 2012 ·PubMed ·(unknown), Alexandre E. Voskuyl, Marc Vervloet, Marc Bijl, Ruud G.L. de Sévaux, Stefan P. Berger, R. H. W. M. Derksen, Jo H. M. Berden	18
17	Platelet- derived growth factor receptor-beta and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study 2011 ·Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) ·(unknown), A. Boonstra, Alexandre E. Voskuyl, M.J. Vonk, A. Vonk Noordegraaf, (unknown), (unknown), B. A. C. Dijkmans, (unknown), Egbert F. Smit, Katrien Grünberg	2
18	Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRÉ Investigation 2008 ·Annals of the Rheumatic Diseases ·Vokko P. van Halm, Matthew Peters, Alexandre E. Voskuyl, Maarten Boers, Willem F. Lems, Marjolein Visser, Coen D.A. Stehouwer, Annemieke M. W. Spijkerman, Joost Dekker, Giel Nijpels, R.J. Heine, L.M. Bouter, Yvo M. Smulders, Ben A. C. Dijkmans, Michael T. Nurmohamed	270
19	Disease modifying anti-rheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study 2006 ·Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) ·(unknown), Michael T. Nurmohamed, Jos W. R. Twisk, (unknown), Alexandre E. Voskuyl	18
20	Symmetrical, painful ulceration of the lower limbs in a vascular surgery ward: a diagnostic challenge. Pyoderma gangrenosum associated with IgG-kappa paraproteinaemia. 2004 ·PubMed ·Suat Şimşek, Rainer Haak, Alexandre E. Voskuyl, Jan A. Rauwerda, R. J. M. Strack van Schijndel	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact